Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Phase 1 Study OF CDC-501 in Patients with Solid Tumors Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified medical advice, calls or professional assistance using a genuine dr.. We aren't physicians. Always confer with your dr. on Phase 1 Study OF CDC-501 in Patients with Solid Tumors conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Phase 1 Study OF CDC-501 in Patients with Solid Tumors Clinical research trials and Phase 1 Study OF CDC-501 in Patients with Solid Tumors medical trials happen in hundreds of localities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new does drugs. The intent of the studies / undertakings is to answer particular human health questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to find cures for all kinds of circumstances, like Phase 1 Study OF CDC-501 in Patients with Solid Tumors. Phase 1 Study OF CDC-501 in Patients with Solid Tumors Clinical Trials and other clinical trials permit volunteers to acquire healthcare treatment options before they are available to the general public. Some times the subjects acquire professional assistance for free, and sometimes they are paid for their time. Sometimes there is a cost for a Phase 1 Study OF CDC-501 in Patients with Solid Tumors clinical trial. Participants frequently obtain the most expert healthcare available for their Phase 1 Study OF CDC-501 in Patients with Solid Tumors condition. Dangers are a reality, nevertheless, and can include more or frequent doctor calls, health risks (potentially life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.

Home > "P" Clinical Trials Conditions > Phase 1 Study OF CDC-501 in Patients with Solid Tumors

Phase 1 Study OF CDC-501 in Patients with Solid Tumors



Phase 1 Study OF CDC-501 in Patients with Solid Tumors

For Condition: Neoplasms
Status: No longer recruiting
Sponsor(s): Celgene Corporation ,
Synopsis: To identify the maximum tolerated dose (MTD) and safety of CDC-501 when given in a 6-week cycle in patients with solid tumors that are refractory after standard treatment.
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Non-Randomized, Open Label, Active Control, Single Group Assignment, Safety Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: - Patient must understand and voluntarily sign an informed consent document. - Age 18 years at the time of signing Informed Consent. - Documented solid tumors that are refractory to standard/conventional therapy or for which no standard/conventional therapy exists. - Patient must be able to adhere to the study visit schedule and other protocol requirements. - Approximate life expectancy greater than 3 months. - Women of childbearing potential (WCBP) must have a negative serum or urine pregnancy test. In addition, sexually active WCBP must agree to use adequate contraceptive methods (oral, injectable, or implantable hormonal contraceptive; tubal ligation; intra-uterine device; barrier contraceptive with spermicide; or vasectomized partner).
Total Enrollment: 24

Location and Contact Information:

Wake Forest University
Winston Salem,  North Carolina,  27157
United States
 


Additional Information:
Study ID Numbers:
  CC-5013-ST-003; 
Study Start Date: June 2002
Record last reviewed: May 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00046735

Other Neoplasms Studies:
1. Kanglaite Injection Phase I Study

2. Collection of Tissue Specimens from Patients with Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members

3. Intrathecal Gemcitibine to Treat Neoplastic Meningitis

4. Cord Blood Stem Cell Transplantation Study (COBLT)

5. Liposome Encapsulated SN38 (LE-SN38) in Patients with Advanced Cancer

Related Studies:

Other Neoplasms Clinical Trials
Other North Carolina Clinical Trials
Other Winston Salem Clinical Trials

Phase 1 Study OF CDC-501 in Patients with Solid Tumors

Modify your Search

  Other Neoplasms Clinical Trials
  Other North Carolina Clinical Trials
  Other Winston Salem Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103